Suggested guidelines for reporting clinical results in transplantation trials

Transplantation Reviews

Volumn 21, Issue 3, 2007, Pages 136-142

  Martini, Sebastian ^a   Glander, Petra ^a   Fritsche, Lutz ^a   Fleiner, Franca ^a   Budde, Klemens ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BIOPSY TECHNIQUE; CHECKLIST; CLINICAL RESEARCH; CLINICAL TRIAL; FUNDING; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; MANDATORY REPORTING; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MORBIDITY; MORTALITY; ORGAN TRANSPLANTATION; PATIENT CARE; POPULATION RESEARCH; POSTOPERATIVE INFECTION; PRACTICE GUIDELINE; PUBLICATION; QUALITY CONTROL; REGISTER; RESEARCH SUBJECT; STANDARDIZATION;

EID: 34548104121     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2007.04.001     Document Type: Article

References (27)

1. Pengel L., Barcena L., and Morris P.J. Registry of randomized controlled trials in transplantation: July 1-December 31, 2005. [corrected]. Transplantation 82 (2006) 1247-1260
2. Pengel L., Barcena L., and Morris P.J. Registry of randomized controlled trials in transplantation: January 1 to June 30, 2005. Transplantation 81 (2006) 1071-1086
3. Begg C., Cho M., Eastwood S., et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276 (1996) 637-639
4. Moher D., Schulz K.F., and Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285 (2001) 1987-1991
5. Chan A.W., and Altman D.G. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 330 (2005) 753
6. Budde K., and Fritsche L. Proposal for guidelines for publication of randomized trials in the American Journal of Transplantation. Am J Transplant 5 (2005) 644-647
7. Barcena L., Pengel L., and Morris P.J. Registry of randomized controlled trials in transplantation. Transplantation 80 (2005) 1525-1534
8. Fritsche L., Einecke G., Fleiner F., Dragun D., Neumayer H.H., and Budde K. Reports of large immunosuppression trials in kidney transplantation: room for improvement. Am J Transplant 4 (2004) 738-743
9. Bulpitt C.J. Confidence intervals. Lancet 1 (1987) 494-497
10. Gardner M.J., and Altman D.G. Using confidence intervals. Lancet 1 (1987) 746
11. Rothman K.J. A show of confidence. N Engl J Med 299 (1978) 1362-1363
12. Fleiner F., Fritsche L., Glander P., Neumayer H.H., and Budde K. Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed or treated rejection?. Transplantation 81 (2006) 655-659
13. Wells A., Watson C., Jamieson N., and Bradley J.A. Which time is it? A suggestion for unambiguous nomenclature in transplantation. Am J Transplant 7 (2007) 1315-1316
14. Humar A., and Michaels M. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 6 (2006) 262-274
15. Farney A., Sundberg A., Moore P., et al. A prospective randomized single center trial of alemtuzumab versus rabbit anti-thymocyte induction in renal and pancreas transplantation: infectious complications. Transplantation 82 1 Suppl 2 (2006) 866-867
16. Guaraldi G., Cocchi S., Codeluppi M., et al. Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients. Transplantation 80 (2005) 1742-1748
17. Malek S.K., Obmann M.A., Gotoff R.A., Foltzer M.A., Hartle J.E., and Potdar S. Campath-1H induction and the incidence of infectious complications in adult renal transplantation. Transplantation 81 (2006) 17-20
18. Michalak G., Kwiatkowski A., Bieniasz M., et al. Infectious complications after simultaneous pancreas-kidney transplantation. Transplant Proc 37 (2005) 3560-3563
19. Juni P., Altman D.G., and Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323 (2001) 42-46
20. Webster A.C., Woodroffe R.C., Taylor R.S., Chapman J.R., and Craig J.C. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 331 (2005) 810
21. Hodson E.M., Jones C.A., Webster A.C., et al. Antiviral medications to prevent Cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 365 (2005) 2105-2115
22. Couser W.G., Drueke T., Halloran P., Kasiske B., Klahr S., and Morris P. Uniform clinical trial registration policy for journals of kidney diseases, dialysis, and transplantation. J Am Soc Nephrol 16 (2005) 837
23. Dickersin K., and Rennie D. Registering clinical trials. JAMA 290 (2003) 516-523
24. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
25. Morris P.J. Quality of randomized trials in solid organ transplantation. Transplantation 80 (2005) 431
26. Kane R.L., Wang J., and Garrard J. Reporting in randomized clinical trials improved after adoption of the CONSORT statement. J Clin Epidemiol 60 (2007) 241-249
27. Plint A.C., Moher D., Morrison A., et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 185 (2006) 263-267